Watanabe Hiroki, Koike Akira, Wu Longmei, Kato Hidenori, Konno Hirotomo, Sato Akira, Kawamoto Hiroaki, Matsumura Akira, Aonuma Kazutaka, Sankai Yoshiyuki, Ieda Masaki
Center for Cybernics Research, University of Tsukuba, Tsukuba, Japan.
Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Cardiology. 2019;142(4):213-219. doi: 10.1159/000500263. Epub 2019 Jun 25.
The hybrid assistive limb (HAL) provides motion assistance based on bioelectrical signals detected on the skin surface when muscle forces are generated. The lumbar-type HAL is expected to expand the therapeutic options for severe cardiac patients who have difficulty in moving on their own legs. We aim to compare the efficacy of exercise therapy performed with assistance from a lumbar-type HAL versus conventional training (sit-to-stand exercise without HAL) in patients with chronic heart failure. This investigation will be a randomized, nonblinded, controlled study. Sixty patients who satisfy the criteria to receive cardiac rehabilitation therapy under the Japanese national insurance system will be enrolled at the University of Tsukuba Hospital. Participants randomly assigned to 2 groups (HAL group and conventional group) at a 1:1 allocation ratio will perform exercise therapy either with HAL or without HAL for 5-30 min once a day for 6-10 days. Outcome parameters will be measured just before and after the completion of the exercise therapy and at 1 year after hospital discharge. The primary outcomes will be the heart rate, blood pressure, subjective ratings of exercise intensity during exercise (Borg scale), number of days from the start of exercise therapy to independent walking and to discharge, and prognosis (mortality and cardiovascular events) over the 1-year period after discharge. The secondary outcomes will be the assessment of heart failure severity, brain natriuretic peptide, grip strength, thigh muscle thickness, isometric knee extensor strength, standing ability, 10-meter walking speed, 6-min walking distance, short physical performance battery, and adverse events. Unpaired t tests will be used for baseline assessments and outcome measures. This is the first randomized controlled study to examine the efficacy and feasibility of lumbar-type HAL in patients with chronic heart failure. If the results confirm beneficial effects in the outcomes of patients with heart failure, this study will add more evidence in support of the use of the lumbar-type HAL as an effective tool in new cardiac rehabilitation programs.
混合辅助肢体(HAL)基于肌肉发力时在皮肤表面检测到的生物电信号提供运动辅助。腰椎型HAL有望为自行行走困难的重症心脏病患者拓展治疗选择。我们旨在比较在慢性心力衰竭患者中,在腰椎型HAL辅助下进行的运动疗法与传统训练(无HAL辅助的坐立运动)的疗效。本研究将是一项随机、非盲、对照研究。符合日本国家保险制度下心脏康复治疗标准的60名患者将在筑波大学医院入组。以1:1的分配比例随机分为两组(HAL组和传统组)的参与者,将分别在有或无HAL辅助的情况下进行运动疗法,每天一次,每次5 - 30分钟,共进行6 - 10天。运动疗法完成前后以及出院后1年将测量结局参数。主要结局将是心率、血压、运动期间运动强度的主观评分(Borg量表)、从运动疗法开始到独立行走和出院的天数,以及出院后1年期间的预后(死亡率和心血管事件)。次要结局将是心力衰竭严重程度评估、脑钠肽、握力、大腿肌肉厚度、等长伸膝力量、站立能力、10米步行速度、6分钟步行距离、简短体能测试电池,以及不良事件。将使用非配对t检验进行基线评估和结局测量。这是第一项随机对照研究,旨在检验腰椎型HAL在慢性心力衰竭患者中的疗效和可行性。如果结果证实对心力衰竭患者的结局有有益影响,本研究将为支持将腰椎型HAL作为新的心脏康复计划中的有效工具提供更多证据。